$0.665
-0.007 (-1.00%)收盤時
CGC 資訊
CGC 事件
Canopy Growth Appoints Sebastian Blote as Country Manager for Germany
Canopy Growth announced the appointment of Sebastian Blote as Country Manager for Germany, effective October 1, 2026. Blote will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections with partners and healthcare professionals, and driving growth to fully capture the significant potential of the German medical cannabis market. He most recently served as European Sales Director, then Digital Sales Director, at a leading European medical cannabis company based in Germany.
Canopy Growth Appoints Sebastian Blote as Country Manager for Germany
Canopy Growth announced the appointment of Sebastian Blote as Country Manager for Germany, effective October 1, 2026. Blote will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections with partners and healthcare professionals, and driving growth to fully capture the significant potential of the German medical cannabis market. He most recently served as European Sales Director, then Digital Sales Director, at a leading European medical cannabis company based in Germany.
Canopy Growth Supplies Medical Cannabis Flowers to the UK
Canopy Growth will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom, expanding the reach of its international cannabis business into another European market. The Canadian-grown flower strains will be supplied to GROW Group U.K., a manufacturer and distributor of prescribed cannabis-based medicines across Europe, which will commercialize the products in the UK under Canopy Growth's global Spectrum Therapeutics medical brand. This initial launch represents the introduction of Canopy Growth's portfolio products into the UK market.
Canopy Growth Expands Medical Cannabis Portfolio in Australia
Canopy Growth announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion introduces two new product formats, and new formulations within its existing oil and softgel ranges.
Company Reports Q1 Revenue of C$100.4M
Reports revenue C$100.4M vs. C$88.7M last year. "The renewed focus and strong momentum we established over the past year have continued into fiscal 2027. In the first quarter, we achieved net revenue growth in every business through solid execution across the organization. We have clear strategies to deliver further growth in each of our end markets. At the heart of our cannabis strategy is our company-wide push to elevate cultivation and produce a consistent and increasing supply of high-quality flower that will support growing demand both in Canada and internationally," said Luc Mongeau, CEO.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。